Immunocore Holdings plc (IMCR)
NASDAQ·Healthcare·Biotechnology
$28.76
+0.70%
Mkt Cap $1.69B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $144.48M | $140.05M | -3.07% | -$0.28 | -$0.60 | -114.29% | — | — |
| Q4 2025 Nov 6, 2025 | $142.21M | $103.69M | -27.09% | -$0.30 | $0.02 | +105.19% | — | — |
| Q3 2025 Aug 7, 2025 | $134.25M | $134.35M | +0.08% | -$0.21 | -$0.20 | +4.76% | — | — |
| Q2 2025 May 7, 2025 | $121.76M | $121.45M | -0.25% | -$0.35 | $0.10 | +128.57% | — | — |
| Q1 2025 Feb 26, 2025 | $85.49M | $105.16M | +23.01% | -$0.31 | -$0.47 | -51.61% | — | — |
| Q4 2024 Nov 6, 2024 | $109.97M | $107.40M | -2.34% | -$0.35 | $0.17 | +148.57% | — | — |
| Q3 2024 Aug 8, 2024 | $95.16M | $95.43M | +0.29% | -$0.45 | -$0.23 | +48.89% | — | — |
| Q2 2024 May 8, 2024 | $88.70M | $88.49M | -0.24% | -$0.33 | -$0.49 | -48.48% | — | — |
| Q1 2024 Feb 28, 2024 | $84.93M | $133.52M | +57.21% | -$0.28 | -$0.40 | -42.86% | — | — |
| Q4 2023 Nov 7, 2023 | $82.12M | $76.17M | -7.25% | -$0.32 | $0.04 | +112.50% | — | — |
| Q3 2023 Aug 10, 2023 | $74.64M | $76.59M | +2.62% | -$0.40 | -$0.37 | +7.50% | — | — |
| Q2 2023 May 10, 2023 | $73.71M | $68.05M | -7.68% | -$0.30 | -$0.43 | -43.33% | — | — |
| Q1 2023 Mar 1, 2023 | $62.46M | $59.07M | -5.43% | -$0.00 | -$0.63 | -185194.12% | — | — |
| Q4 2022 Nov 9, 2022 | $43.63M | $45.58M | +4.48% | -$0.26 | $0.14 | +153.85% | — | — |
| Q3 2022 Aug 10, 2022 | $25.47M | $38.85M | +52.54% | -$0.72 | -$0.17 | +76.39% | — | — |
| Q2 2022 May 11, 2022 | $29.65M | $29.48M | -0.60% | -$1.07 | -$0.48 | +55.14% | — | — |
| Q1 2022 Mar 3, 2022 | $10.46M | $8.89M | -14.95% | -$1.08 | -$1.21 | -12.04% | — | — |
| Q4 2021 Nov 10, 2021 | $9.03M | $8.00M | -11.42% | -$0.85 | -$0.93 | -9.41% | — | — |
| Q3 2021 Aug 11, 2021 | $10.95M | $7.92M | -27.67% | -$0.95 | -$1.04 | -9.47% | — | — |
| Q2 2021 May 12, 2021 | $10.38M | $11.43M | +10.03% | -$0.83 | -$0.92 | -10.84% | — | — |